Skip to main content
Caplight Logo









Navinci Diagnostics

Navinci Diagnostics

Private
UppsalaHealthcare & Life Scienceshttps://navinci.se/

Last Round

Early Funding

Jun 25, 2025

Total Funding Raised

$14.66M

Company Overview

Navinci Diagnostics is a biotechnology company that develops and markets in situ proximity ligation assays to detect proteins, their interactions, and modifications in tissue and cell samples.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

spatial proteomicsin situ Proximity Ligation AssayisPLAprotein interaction analysisspatial biologyassay kitslife science toolsPTM detectionin situ analysismultiplex assaybiomarker discoveryimmuno-oncologydrug developmentspatial interactomicsneurosciencepathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Navinci Diagnostics Comparables

Compare Navinci Diagnostics with similar companies based on industry and business-model similarity.

Navinci Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pixelgen Technologies
81%
Bio-Techne Corporation
76%
Vizgen
76%

Navinci Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJun 25, 2025
Series AJul 12, 2022

Key People

Founding team and executive leadership

Jenny Sundqvist

Chief Executive Officer

Executive Team

Magnus Hurst

CFO

Executive Team

Navinci Diagnostics Investors

Notable investors and investment history

Navinci Diagnostics investors
InvestorRounds
Meltwind AdvisoryEarly Funding
Segulah Medical AccelerationEarly Funding, Series A
NXT2BSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 42% MoM, reaching 8.8K.

  • Jan 22, 2026

    Monthly visitors increased 60% MoM.

Navinci Diagnostics Filings

Explore SEC and related filing metadata, where available.

Navinci Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Navinci Diagnostics's valuation, stock price, and market status.

Is Navinci Diagnostics a public or private company?

Navinci Diagnostics is a private company.

What is the current stock price of Navinci Diagnostics?

Navinci Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Navinci Diagnostics worth (valuation)?

Valuation information for Navinci Diagnostics is not publicly available.

Can I buy Navinci Diagnostics stock?

Navinci Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Navinci Diagnostics's last funding round?

Funding round information for Navinci Diagnostics is not publicly available.

Who are the main investors in Navinci Diagnostics?

Investor information for Navinci Diagnostics is not publicly disclosed.

Will Navinci Diagnostics IPO soon?

No public IPO plans have been announced for Navinci Diagnostics.

How can I track Navinci Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Navinci Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUppsala
Employee Range28
Year Founded2004
Last FundingJun 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?